MVR - Dr. Narayanankutty Warrier

Dr. Narayanankutty Warrier
Medical Oncology
MEDICAL DIRECTOR

<div></div> <div> Email official : ✦ <a href="mailto:drsudheesh@mvrccri.co" style="color: #0056b3;">drnkwarrier@mvrccri.co</a> Qualification: ✦ Fellow of Royal College of Physicians ✦ Edinburgh – UK ( FRCP ) ✦ DM (Medical Oncology ) ✦ MD ( General Medicine ) Profile: WORK EXPERIENCE ✦ Sr. Lecturer and consultant , General Medicine , Govt Medical College Calicut ( 1996 -1998) ✦ Sr. Lecturer & Consultant , Medical Oncology , Govt Medical College Calicut ( 2000 -2003) ✦ Ast. Professor & Sr Consultant , Medical Oncology , Govt Medical College Calicut ( 2003 -2006) ✦ Sr.Consultant and HOD, Dept of Medical and Paediatric Oncology , MIMS Calicut (2006 – 2017) ✦ Medical Director & Senior Consultant , Medical Oncology , MVR Cancer Centre and Research Institute ,Calicut ( 2017 – continuing ) Clinical interest : ✦ Medical Oncology Publications : ✦ Triple-negative and non–triple-negative breast cancer in a south Indian cohort. - Narayanankutty Edavalath Warrier, Uma V Sankar, Sreedharan P S, Ajmal Sherif - J Clin Oncol 38: 2020 (suppl; abstr e13110) 10.1200/JCO.2020. 38.15_suppl.e13110. ✦ 'Detect Early Be Safe–Care for Mother (DEBS-CaM)' project: School-based interventionsto improve awareness and screening for breast cancer among the young mothers of Kerala- Narayanankutty Warrier, Uma V Sankar, Sreedharan P S, Nirmal V, Sajeevan K V, Ajmal Sherif Clin Oncol 38: 2020 (suppl; abstr e13570) ✦ Clinical audit of a Paediatric Emergency Warning Score (PEWS) in the paediatric oncology unit of a newly established tertiary cancer institute. Pediatric Hematology,Oncology- Yamini Krishnan,Gazel Sainulabdin, V. Sankar Uma, P.S. Sreedharan,Narayanankutty Warrier - Journal 2020 (5) 69-74 ✦ Maintenance Therapy for Recurrent Epithelial Ovarian Cancer: Current Therapies and Future Perspectives A Review: Sudeep Gupta1, Shona Nag2, Shyam Aggarwal3, Amit Rauthan4, Narayaankutty Warrier5:Indian Journal of Cancer, October 2018 on print. ✦ Epidermal Growth Factor Receptor (EGFR) Mutation Testing: From Conventional to Real-Time Diagnosis ofLung Cancer, T Raja, N K Warrier Indian Journal of Cancer,December 2017:Volume 54,Issue 5. ✦ Epidemiology of mutations in Lung Cancer in Indian Patients-Narayanankutty Warrier, Lecture in World CancerCongress XVII Barcelona, Spain, May 17th 2017. ✦ Infections and Febrile Neutropenia in Pediatric Acute Lymphoblastic Leukemia Patients from South India: Microbial Profile and Outcome Analysis, BinduKanathezhath, Amritha Radhakrishnan, Sujithkumar and Narayanankutty Warrier,Blood Journal, December 7, 2015. ✦ Linear accelerator based blood irradiation for paediatric oncology practice in limited resource setting:Illumination and Innovation. Sujith Kumar.M, Sandeep M, Aswathy Raj, Bindu.K.Sathi, Sathish Padmanabhan, Narayanankutty EdavalathWarrier, Journal of Clinical Oncology, May 2014. ✦ Chronic myeloid leukaemia – Clinical Profile and Outcome. Narayanankutty Warrier P.K. Sasidharan, P.Majeed. 44th Annual National Conference of Indian Society of Haematology & Transfusion Medicine 2004. ✦ Immune thrombocytopenic purpura. Narayanankutty Warrier, P.K. Sasidharan, P. Majeed. 44th Annual National Conference ofIndian Society of Haematology, Transfusion Medicine 2004 ✦ Screening for Cancer-Indian scenario. Narayanankutty Warrier, Association of Physicians of India - Annual Conference 2004. ✦ Intracardiac metastases from a testicular germ cell tumour, - V Talwar, Praveen Sreedharan, Narayanan Warrier, T G Sagar, The Journal of the Association of Physicians of India, Jul 2002. ✦ Neutropenic Sepsis - An Overview, Narayanankutty Warrier, 43rd Annual National Conference of Indian Society of Haematology & Transfusion Medicine 2002. ✦ Acute Lymphoblastic Leukemia Presenting as Breast Mass, The Journal of the Association of Physicians of India, V Talwar, Praveen Sreedharan, Narayanan Warrier T G Sagar, Jan 2001 ✦ Epidemiological and Demographic Data of patients attending Medical Oncology, Calicut, 2001 Narayanankutty Warrier, Sunny Varghese, Proc. Of ISO !Xth Biennial Conference of Indian Society of Oncology – 2001. ✦ Bilateral Primary NHL of the Breast, Narayanankutty Warrier, Vineet Talwar Sreedharan P.S, XV APCC, 1999 Chennai. ✦ Interferon Therapy for CML 1990 to 1998. Cancer Institute of Experience Chennai Experience Narayankutty Warrier, Vineet Talwar, Sreedharan P.S, XV APCC, 1999 Chennai. ✦ Outcome of GCT of Ovary. Management with BEP - Cancer Institute Experience Narayanankutty Warrier, Vineet Talwar, Sreedharan P.S, XV APCC, 1999 Chennai. ✦ Treatment of Ca ovary with Taxol – Cancer Institute Experience Narayanankutty Warrier, Vineet Talwar, Sreedharan P.S, XV APCC, 1999 Chennai. Education : ✦ FRCP - 2019 , Royal College of Physicians , Edinburgh , UK ✦ DM – 2000, Cancer Institute Adayar , Tamil Nadu ✦ MD – 1996 ,Govt Medical College , Calicut ✦ MBBS – 1989 ,Govt Medical College , Calicut Achievements: ✦ Inducted as a fellow of the Royal College of Physicians Edinburgh UK in 2019 ✦ Selected as one of the twelve world leaders of Oncology by 2018 American Society of Clinical Oncology (ASCO) Annual meeting held on June 1st 2018. ✦ CH Centre State Award 2018. ✦ MSF State Award 2015. ✦ GIANTS International Achievers Award 2014 ✦ Indian Medical Association-AMS Fellowship 2005. ✦ American Society of Clinical Oncology, ASCO Foundation International Development and Education Award (IDEA) 2004. </div>

Book Now

Donate now

Dr. Narayanankutty Warrier

Doctor

MV RAGHAVAN The Visionary